As we aimed to identify potential biomarkers for diagnostic purposes in vitro and to assess these markers in vivo, we investigated the QSOX1, THBS1 and EDIL3 levels in blood plasma obtained from patients 1–3 prior to tumour resection. Here, THBS1 is linked to neoplasm.